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ABSTRACT: Gemcitabine is a modiﬁed cytidine analog having
two ﬂuorine atoms at the 2′-position of the ribose ring. It has
been proposed that gemcitabine inhibits RNR activity by pro-
ducing a C3′• intermediate via direct H3′-atom abstraction
followed by loss of HF to yield a C2′• with 3′-keto moiety.
Direct detection of C3′• and C2′• during RNR inactivation
by gemcitabine still remains elusive. To test the inﬂuence of
2′- substitution on radical site formation, electron spin resonance
(ESR) studies are carried out on one-electron oxidized gemcitabine
and other 2′-modiﬁed analogs, i.e., 2′-deoxy-2′-ﬂuoro-2′-
C-methylcytidine (MeFdC) and 2′-ﬂuoro-2′-deoxycytidine
(2′-FdC). ESR line components from two anisotropic β-2′-F-atom hyperﬁne couplings identify the C3′• formation in one-
electron oxidized gemcitabine, but no further reaction to C2′• is found. One-electron oxidized 2′-FdC is unreactive toward
C3′• or C2′• formation. In one-electron oxidized MeFdC, ESR studies show C2′• production presumably from a very unstable
C3′• precursor. The experimentally observed hyperﬁne couplings for C2′• and C3′• match well with the theoretically predicted
ones. C3′• to C2′• conversion in one-electron oxidized gemcitabine and MeFdC has theoretically been modeled by ﬁrst
considering the C3′• and H3O+ formation via H3′-proton deprotonation and the subsequent C2′• formation via HF loss induced
by this proximate H3O
+. Theoretical calculations show that in gemcitabine, C3′• to C2′• conversion in the presence of a
proximate H3O
+ has a barrier in agreement with the experimentally observed lack of C3′• to C2′• conversion. In contrast, in
MeFdC, the loss of HF from C3′• in the presence of a proximate H3O+ is barrierless resulting in C2′• formation which agrees
with the experimentally observed rapid C2′• formation.
■ INTRODUCTION
Gemcitabine is a modiﬁed cytidine analog having two ﬂuorine
atoms at the 2′-position in the deoxyribose sugar moiety
(Scheme 1). For nearly 20 years, it has been widely used to
treat speciﬁcally pancreatic cancer.1−4 It has been proposed that
gemcitabine inhibits ribonucleotide reductase (RNR) activity5−7
as well as acting as a replication stop,8,9 thereby aﬀecting DNA
synthesis and elongation.
It is well established that in the absence of oxygen, thiyl
radicals are able to abstract hydrogen (H) atoms to form
neutral C-centered radicals. For example, H-atom abstraction
by thiyl radicals has been shown to induce isomerization of cis-
2,5-dimethyltetrahydrofuran to the trans-2,5-dimethyltetrahy-
drofuran.10,11 On this basis, Stubbe et al.,5−7 in their enzymatic
and electron spin resonance (ESR) studies with gemcitabine,
have proposed that inhibition of the RNR activity by gemcitabine
should occur via radical formation at the C3′ site by direct
H-atom abstraction to produce a C3′• via a enzymatic thiyl
radical (reaction 1). Subsequently, the C3′• intermediate has
been proposed to form 3′-keto C2′• via HF loss. This C2′• is
stabilized by an oxy radical resonance contribution (reaction 2).
C2′• and its immediate precursor C3′• (reactions 1 and 2) play
a key role in the RNR inactivation.5−7
The H-atom abstraction reaction (reaction 1) is not only
important in RNR activation but also plays a very key role
toward stable product formation in other biologically damage
processes in DNA, such as oxidative intrastrand cross-link
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Scheme 1. Structural Formula of Gemcitabine Including the
Standard Numbering Convention for Atoms According to
IUPAC Nomenclaturea
aThe two highly electronegative F-atoms at C2′ substantially increase
the acidity of H3′ through the inductive eﬀect.
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formation12 and in the formation of sugar radicals that are strand
break precursors.13,14
Theoretical modeling,15,16 along with chemical biomimetic
studies by Giese et al.,17 by Robins et al.18,19 as well as
McCarthy’s 2′-deoxy-2′-ﬂuoromethylenecytidine20,21 support the
mechanism shown in reactions 1 and 2. It is noteworthy that
pulse radiolysis experiments with a 1,4-anhydro-5-deoxy-6-thio-
D-ribo-hexofuranitol detected the formation of ribosyl-based
carbon-centered radical(s) after H-atom abstraction by thiyl
radicals.22 These studies are supportive of reactions 1 and 2 but
unequivocal, and direct detection of C3′• and C2′• employing
ESR or pulse radiolysis during RNR-catalyzed deoxygenation of
the natural substrates23−25 or during inactivation by gemcitabine
still remains elusive.
In this work, we report the formation of C2′• from a likely
C3′• in a gemcitabine analog which mimics the mechanism
proposed above. From the structural formula of gemcitabine
(Scheme 1), it is expected that the negative inductive eﬀect (−I)
of two highly electronegative F-atoms at C2′ should increase the
acidity of H3′. From our previous work on nucleoside cation
radicals,26−38 the gemcitabine cation radical formed upon one-
electron oxidation is expected to produce C3′• after deprotona-
tion of the acidic proton H3′. In this work, ESR spectroscopy
has been employed to investigate one-electron oxidation of
gemcitabine and other 2′-modiﬁed derivatives, for example,
2′-deoxy-2′-ﬂuoro-2′-C-methylcytidine (MeFdC (PSI-6130);
Scheme 2)39−42 and 2′-ﬂuoro-2′-deoxycytidine (2′-FdC,
Scheme 2), in order to test the inﬂuence of 2′- substituent on
radical site formation. It is noteworthy that MeFdC is a well-
known clinically eﬃcacious inhibitor of hepatitis C virus.39,42
The ESR results clearly identify the C3′• formation in one-
electron oxidized gemcitabine and the production of C2′• in
one-electron oxidized MeFdC. These ESR studies are supported
by density functional theory (DFT) calculations. These calcula-
tions show that in the case of one-electron oxidized MeFdC, the
lowest energy path is the rapid formation of C2′• from C3′• via
F− loss. This F− loss is a barrierless reaction between the
2′-F-atom and the proximate H3O+ which was formed via
deprotonation of H3′ in the cation radical.
■ MATERIALS AND METHODS
Compounds. Gemcitabine (Scheme 1) and 2′-FdC (Scheme 2)
were obtained from Carbosynth Ltd. (Berkshire, UK). MeFdC
(Scheme 2) was prepared as described39 or purchased from ADooQ
Bioscience (Irvine, CA).
Lithium chloride (LiCl) (ultra dry, 99.995% (metals basis)) was
obtained from Alfa Aesar (Ward Hill, MA, USA). 2′-Deoxycytidine
(2′-dC) was obtained from Sigma Chemical Company (St Louis, MO,
USA). Deuterium oxide (D2O) (99.9 atom % D) was purchased from
Aldrich Chemical Co. Inc. (Milwaukee, WI, USA). Potassium per-
sulfate (K2S2O8) was procured from Mallinckrodt, Inc. (Paris, KY,
USA). Cytidine-5,6-d2 ([5,6-D,D]-Cyd, 99 atom % D) was purchased
from CDN Isotopes (Quebec, Canada). All compounds were used
without further puriﬁcation.
Preparations of Samples. Preparation of Homogeneous
Solutions. Homogeneous solutions of gemcitabine were prepared by
dissolving 2−10 mg/mL either in 7.5 M LiCl in D2O or in H2O.
Solutions of other compounds (2′-dC, 2′-F-dC, MeFdC, and [5,6-
D,D]-Cyd) were prepared by dissolving ca. 2−3 mg/mL in 7.5 M LiCl
in D2O. K2S2O8 (6−16 mg/mL) was added as an electron scavenger
so that only the formation of the one-electron oxidized species and its
subsequent reactions can be followed by employing ESR spectroscopy.
The above-mentioned procedure for preparation of solutions is
according to our ongoing studies on various model systems of DNA
and RNA.26−38
Scheme 2. Structural Formulae of the Compounds (Apart from Gemcitabine (Scheme 1)) Used in This Work
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pH Adjustments. The pH of gemcitabine in 7.5 M LiCl/D2O
was adjusted to the range of ca. 8−12 depending on the experiment.
The pH of gemcitabine in 7.5 M LiCl/H2O and the pH of other
compounds (2′-dC, 2′-F-dC, MeFdC, and [5,6-D,D]-Cyd) in 7.5 M
LiCl/D2O was adjusted at pH ca. 10. These pH adjustments were
performed by adding μL amounts 1 M NaOH as per our previous
eﬀorts.26−30,32,38 These solutions have high ionic strength (7.5 M LiCl);
therefore, the pH meters would not provide accurate pH measurements
of these solutions. Instead, as per our previous works,26−30,32,38 pH
values reported in this work were obtained using pH papers and are
approximate measurements.
Preparation of Glassy Samples and Their Storage. As per our
previous works,26−30,32,38 these pH-adjusted homogeneous solutions
were thoroughly bubbled with nitrogen to remove the dissolved
oxygen. Immediately, these solutions were drawn into 4 mm Suprasil
quartz tubes (Catalog no. 734-PQ-8, WILMAD Glass Co., Inc., Buena,
NJ, USA) and were rapidly cooled in liquid nitrogen (77 K). The rapid
cooling of these homogeneous liquid solutions at 77 K leads to the
formation of transparent homogeneous glassy solutions. These glassy
solutions were later used for the irradiation and subsequent progressive
annealing experiments. All glassy samples were stored at 77 K in Teﬂon
containers in the dark.
Irradiation and Storage of γ-Irradiated Glassy Samples. All
samples were γ (60Co)-irradiated (absorbed dose =1.4 kGy) at 77 K
and stored at 77 K in Teﬂon containers in dark following our previous
eﬀorts.26−30,32,38
Annealing of Glassy Samples. A variable-temperature assembly
was employed which passed liquid nitrogen cooled nitrogen gas past
a thermister and over the sample as described in our earlier studies.27
The glassy samples have been annealed anywhere from (140−170) K
for 15 min. Annealing leads to one-electron oxidation of the solute by
the matrix radical Cl2•− thus, forming only the cation radical of the
solute, e.g., gemcitabine.
Electron Spin Resonance. Following our earlier studies,26−30,32,38
immediately after γ-irradiation of the glassy sample at 77 K, the ESR
spectrum was recorded at 77 K. Also, immediately after each annealing
step, the sample was cooled to 77 K by immersing in liquid nitrogen
(77 K), and the ESR spectrum was recorded at 77 K which maximizes
signal height and allows for comparison of signal intensities. A Varian
Century Series X-band (9.3 GHz) ESR spectrometer with an E-4531
dual cavity, 9 in. magnet, and a 200 mW Klystron was used, and
Fremy’s salt (gcenter = 2.0056, A(N) = 13.09 G) was employed for the
ﬁeld calibration. All ESR spectra have been recorded at 77 K and at
40 dB (20 μ W).
Anisotropic simulations of ESR spectra have been performed using
the WIN-EPR and SimFonia programs of Bruker as per our previous
works.26,28−38,43 The simulated spectra thus obtained were compared
to experimental spectra, and ESR parameters were adjusted for the
best ﬁt26,28−38,43 (also Supporting Information Figure S3).
Calculations Based on DFT. Theoretical calculations were
performed using the Gaussian 09 program.44a GaussView44b and
JMOL44c programs were used to plot the spin densities and molecular
structures. The geometries of all the radicals considered in the present
study were fully optimized using the ωb97x functional45 and 6-31G(d)
basis set. We note here that ωb97x functional was developed by
the group of Head−Gordon and found to be very successful for the
calculations of various properties of molecules in their diﬀerent spin
states.45,46 The hyperﬁne coupling constants (HFCCs) of the radicals
were calculated using the same method and basis set, i.e., ωb97x/
6-31G(d) in the gas phase. In order to treat the eﬀect of solvent on HF
loss from the C3′• in gemcitabine and in MeFdC, we employ the
integral equation formalism polarized continuum model47 (IEF-PCM)
as implemented in Gaussian 09. In addition to PCM, for C3′• in both
systems a H3O
+ is placed in the vicinity of the C3′-OH bond for C3′•
in gemcitabine and for C3′• in MeFdC and have optimized the
structures. The electronic energy proﬁle of F− dissociation from C2′
site of C3′• in MeFdC as well as the electronic energy proﬁle of
F− dissociation for each of the two F-atoms from C2′ site of C3′• in
gemcitabine were obtained in the presence of a single water molecule
at the same level of theory (Supporting Information Figure S4C,D).
Furthermore, employing the wb97x/6-31++G(d,p) method along with
the IEF-PCM model for the solvent eﬀect, the pKa of the C3′-OH
group for the C3′• of gemcitabine and also of the C3′-OH group for
the C3′• of 2′-dC was calculated.
■ RESULTS AND DISCUSSION
Experimental Section. C3′• Formation via One-Electron
Oxidation of Gemcitabine in the pH Range ca. 7−12. In
Figure 1A, we show the experimentally recorded (77 K) ESR
spectrum (green) of one-electron oxidized gemcitabine at pH
(pD) ca. 7 in a homogeneous glassy 7.5 M LiCl/D2O solution.
The one-electron oxidation of gemcitabine was induced by
Cl2•− attack after annealing at 155 K in the dark. The computer
simulated spectrum is shown in blue.
Matched samples of gemcitabine at pDs ranging from ca.
9−12 showed identical spectra after one-electron oxidation of
gemcitabine by Cl2•− on annealing at 150−155 K. Thus, only
the spectrum obtained from the gemcitabine sample at pD ca.
10 is presented in Figure 1B along with the simulated spectrum
in blue. It is evident from Figure 1A,B, the line shape, total
hyperﬁne splitting, and the center of the simulated spectra
match with those of the experimentally recorded spectra
quite well.
Each of the spectra in Figure 1A,B show two anisotropic
β-F-atom hyperﬁne couplings and a β-H-atom hyperﬁne coupling.
The β-H-atom hyperﬁne coupling creates the doublet splitting in
the line components in Figure 1A,B.
Figure 1A is best matched with a simulation employing the
two diﬀerent anisotropic β-F-atom (nuclear spin = 1/2) HFCC
values of (15.0, 15.0, 105) G and (15.0, 15.0, 69.0) G, one β-H
HFCC as (15.0, 15.0, 24.0) G, gxx, gyy, gzz (2.0080, 2.0050,
2.0020) along with a mixed (Lorentzian/Gaussian (1:1)) line-
width of 14 G. The simulated spectrum in blue is superimposed
on the experimentally recorded spectrum in Figure 1A. On the
other hand, the best ﬁt for Figure 1B is obtained employing the
two identical anisotropic β-F-atom (nuclear spin = 1/2) HFCC
Figure 1. ESR spectra obtained from matched gemcitabine samples
[concentration of gemcitabine in each sample = 2 mg/mL in 7.5 M
LiCl/D2O] in the presence of the electron scavenger K2S2O8 (8 mg/mL
in each sample). Each sample has been γ-irradiated (absorbed dose =
1.4 kGy at 77 K), subsequently annealed to 155 K for 15 min in the dark
at various pHs (A) pH ca. 7 (green) and (B) pH ranging ca. 9−12
(pink). Here the spectrum recorded at pH ca. 10 is shown. The blue
spectra that are superimposed on the experimentally recorded spectra
are the simulated spectra of C3′•. See text for the details of simulation.
All ESR spectra are recorded at 77 K. The three reference markers
(open triangles) in this ﬁgure and in the subsequent ﬁgures show the
position of Fremy’s salt resonance with the central marker at g = 2.0056.
The spacing separating the markers is 13.09 G.
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as (17.0, 17.0, 86.0) G, one β-H HFCC as (15.0, 15.0, 24.0) G,
gxx, gyy, gzz (2.0060, 2.0050, 2.0020) along with a mixed
(Lorentzian/Gaussian (1:1)) line-width of 10 G.
Following our work on the radicals produced in monomers
of DNA and RNA,28−38,43 the A∥ (i.e., the Azz) component of
each of the two anisotropic β-F-atoms (see Table 1) as well as
the A∥ of the β-H are directly measured from the width of the
experimentally recorded spectra with an uncertainty of ±2 G
(see Supporting Information Figure S3). On the other hand,
the theoretically obtained values of Axx and Ayy components
of each of the two anisotropic β-F-atoms and of the β-H-atom
in Table 1 were adjusted to ﬁt the experimentally recorded
spectra with estimated uncertainty of ±4 G (see Supporting
Information Figure S3).
Thus, the one-electron oxidized gemcitabine spectrum at pH
ca. 7 show two nonequivalent anisotropic β-F-atom HFCCs,
whereas, the one-electron oxidized gemcitabine spectrum at
pH ca. 10 shows two equivalent anisotropic β-F-atom HFCCs.
The β-H-atom HFCC does not show any observable change in
the one-electron oxidized gemcitabine spectrum throughout the
pH range ca. 7−12.
The coupling to two β-F-atoms (C2′) and one β-H-atom
(C4′) is clear evidence for the generation of C3′• after one
electron oxidation of gemcitabine at 150−155 K. The electron-
withdrawing eﬀect of the two electronegative F-atoms at C2′
increases the acidity of H3′, which leads to deprotonation (see
Supporting Information Table T2) and prevents observation
of the initially formed cytosine base π-cation radical (C•+)
in gemcitabine as indicated in reaction 3. Therefore, the
mechanism of C3′• formation due to one-electron oxidation
of gemcitabine is proposed as follows: one-electron oxidation
of gemcitabine results in the formation of metastable C•+,
which is unstable even at ca. 155 K. The metastable C•+
quickly deprotonates at C3′ in the sugar moiety producing
C3′• (reaction 3) via a proton-coupled electron-transfer (PCET)
mechanism.
Origin of the pH Eﬀect. As is evident from the HFCC
values of the spectra shown in Figure 1 and also in Table 1, the
pH of the solution clearly aﬀects the individual β-F-atom
anisotropic HFCC but not the sum of the two β-F-atom
anisotropic HFCC along with the C4′ β-proton HFCC (see
section above). At pH ca. 9−12, the two β-F-atom anisotropic
HFCCs are equivalent; whereas, at pH ca. 7, the sum of the
two β-F-atom anisotropic HFCCs remain the same, but they
individually diﬀer.
The presence of two 2′-F-atoms in gemcitabine will lower the
pKa value of both H3′ and C3′-OH hydrogens. For example, the
OH in 2,2-diﬂuoroethanol has its pKa lowered by 3.5 units in
comparison with ethanol.48 Further, radical formation has also
been shown to lower the pKa of the alcoholic OH group (e.g.,
pKa (CH3)2CHOH = 17.1, pKa (CH3)2C·OH = 12.03).
49 Based
on these factors, the pKa value of the C3′-OH group for C3′•
in gemcitabine is estimated to be in the range of 7−9.
Table 1. Comparison of the Experimentally Obtained HFCCs Values of C3′• and C2′• in Gauss (G) with Those Obtained by
Calculation Using DFT/ωb97x/6-31G(d) Method
HFCC (G)
theory expa,b
molecule radical atoms AIso AAniso A(total)
a A(total)
a,b
gemcitabine C3′• pH ca. 7 two β-F-atoms (C2′) 37.24 Axx −14.61 22.63 15.0
Ayy −13.95 23.29 15.0
Azz 28.56 65.8 69.0
69.55 −29.79 39.76 15.0
−27.76 41.79 15.0
57.55 127.1 105.0
β-H-atom (C4′) 28.61 −1.73 26.88 15.0
−1.03 27.58 15.0
2.76 31.37 24.0
C3′• pH ca. 9−12 two β-F-atoms (C2′) 17.0
17.0
86.0
β-H-atom (C4′) 15.0
15.0
24.0
MeFdCc C2′• three β-H-atoms CH3 group 17.5d (average) 21.5
one β-H-atom (C1′-H) 23.31 −1.77 21.54 25.5
−0.73 22.77
2.51 25.82
aA(total) = AIso + AAniso.
bExperiments give the magnitude but not the sign of the couplings. Estimated errors are of ±2 G for Azz and ±4 G for Axx and
also for Ayy. See Supporting Information Figure S3 for details.
cCalculated in the presence of one water molecule dOnly isotropic HFCC values have
been considered.
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Employing DFT/ωb97x/6-31++G(d,p) method along with the
IEF-PCM model for the solvent eﬀect, the pKa value of the C3′-
OH group for C3′• in 2′-dC has been calculated as 14.2. The
same level of calculation for the C3′-OH group of C3′• in
gemcitabine which replaces each of the two hydrogens at C2′
with ﬂuorine predicts a pKa of 6.8 (see Supporting Information
pages S8, S9). Therefore, the two 2′-F-atoms are predicted to
lower the pKa of the C3′-OH group in C3′• by 7 full units.
Considering the sensitivity of the calculations for predicting pKa
to the small changes in free energy,37 these results are very
reasonable. Furthermore, the theoretically calculated pKa value
6.8 of the C3′-OH group for C3′• in gemcitabine is in good
agreement with its experimentally estimated value (7−9).
The spectrum in Figure 1A (pH ca. 7) should therefore be
for C3′• in gemcitabine with a C3′-OH group and the
spectrum in Figure 1B (pH ca. 9−12) should be for C3′• with
the deprotonated group, i.e., C3′-O− (reaction 4). Thus, we
attribute the variation of the two β-F-atom anisotropic HFCC
to the deprotonation of the C3′-OH group at higher pHs.
Inﬂuence of the Solvent (D2O vs H2O) on One-Electron
Oxidation of Gemcitabine. ESR spectral studies of one-
electron oxidation of gemcitabine in H2O glasses (7.5 M LiCl/
H2O) were performed and compared with the results found
in D2O glasses (7.5 M LiCl/D2O). These results are shown in
Supporting Information Figure S1. No observable diﬀerence in
spectra other than a small line broadening was observed on
formation of C3′• in H2O glasses versus in D2O glasses. Since
C3′• only has the C3′-OH as an exchangeable proton at pH 7
and this does not contribute to a signiﬁcant hyperﬁne coupling,
the ESR spectrum found on formation of C3′• is not altered by
a change of the solvent from D2O to H2O.
C2′• Formation in One-Electron Oxidized, 2′-Deoxy-2′-
ﬂuoro-2′-C-methylcytidine (MeFdC). Similar experiments to
those performed for gemcitabine were carried out for the methyl/
ﬂuoro analog MeFdC (Scheme 2). Using MeFdC, we investigated
whether the formation of C3′• observed in gemcitabine bearing
geminal diﬂuoro unit at C2′ (Figure 1) is aﬀected by the
substitution of one of the F-atoms (−I) with a methyl (Me)
group (+I). The results are presented in Figure 2.
Shown in Figure 2A is the ESR spectrum (black) of a
matched sample of MeFdC that has been γ-irradiated (absorbed
dose = 1.4 kGy), subsequently annealed to 155 K for 15 min in
the dark, and recorded at 77 K.
Figure 2B was obtained by annealing this sample for 15 min
to 170 K. Comparison of spectrum 2A with spectrum 2B shows
clearly that a central doublet decreases along with an increase
of the other line components upon annealing. Therefore,
the central doublet (black) shown in Figure 2C is isolated
by subtraction of 60% of the spectrum 2B from spectrum 2A.
The doublet due to C•+ spectrum (blue) in 2′-dC (see
Supporting Information Figure S2 and its discussion (pp S3−
S5)) is superimposed on it for comparison. From the spectral
similarities of both doublets, the doublet in black shown in
Figure 2C is assigned to C•+ in MeFdC.
Subtraction of 50% C•+ spectrum 2C (black) from spectrum
2A results in the black spectrum shown in Figure 2D. This
overall quintet spectrum arises from 4 isotropic β-proton
couplings: three methyl β-protons (ca. 21.5 G each) and an
isotropic splitting of ca. 25.5 G due to a β-proton assigned to
the C1′-H (vide infra). The experimental (black) spectrum is
simulated using the above-mentioned HFCC values along with
a 10 G line-width and g-value = 2.0033 (this g-value is typical
for C-centered sugar radicals).28,32,33,35,36,38,50−55 The simu-
lated spectrum (red) in Figure 2D matches the overall line
components of the experimental spectrum well. Since the C2′•
(reaction 5) is the only likely radical structure that would
explain the large hyperﬁne coupling to a methyl group and the
additional β-proton hyperﬁne coupling (assigned to C1′), the
experimental spectrum in Figure 2D has been assigned to C2′•
(reaction 5).
The spectra 2A and 2B are a composite of C•+ (black,
Figure 2C) and C2′• (black, Figure 2D) in diﬀerent amounts.
Under the same constant gain and constant microwave power
and upon gradual and stepwise annealing of the sample from
155 K (spectrum 2A) to 170 K (spectrum 2B), no loss of spectral
intensity was observed, and our analyses show an additional
(ca. 20%) conversion of the C•+ to C2′•.
Consideration of the results presented in Figures 1 and 2
suggest that for MeFdC, C•+ is produced ﬁrst and on annealing
converts to a transient C3′•, which is not observed. In contrast,
the line shape, line width, and the overall hyperﬁne splitting
of the C3′• spectrum in gemcitabine do not change upon
annealing to ca. 165 K (i.e., within the temperature range 155−
165 K). Thus, unlike the rapid conversion of C3′• to C2′•
found in one-electron oxidized MeFdC, a similar conversion of
Figure 2. (A) ESR spectrum (black) obtained from MeFdC
[concentration = 2 mg/mL in 7.5 M LiCl/D2O] in the presence of
the electron scavenger K2S2O8 (8 mg/mL), pH ca. 10, γ-irradiated to a
dose of 1.4 kGy at 77 K and subsequently annealed to 155 K for
15 min. (B) Annealed to 170 K for 15 min. (C) Spectrum (black)
obtained after subtraction of 60% of spectrum (B) from spectrum (A).
For comparison, the C•+ spectrum (blue) in 2′-dC (Supporting
Information Figure S2 and pp S3−S5) is superimposed. (D) Spectrum
(black) assigned to C2′• is obtained after subtraction of 50% of
spectrum (C) from spectrum (A). The simulated C2′• spectrum (for
simulation parameters see Figure 2 and text) is superimposed on the
experimentally isolated spectrum for comparison. All the spectra are
recorded at 77 K.
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C3′• to C2′• is not observed for one-electron oxidized
gemcitabine at these low temperatures. The lack of observation
of the transient C3′• in one-electron oxidized MeFdC and the
low temperatures employed in these experiments implies a very
low activation barrier for the conversion of C3′• to C2′•;
whereas, the activation barrier for the conversion of C3′•
to C2′• for one-electron oxidized gemcitabine should be
≥4 kcal/mol. Calculations suggest that the proximity of the lost
H3′ proton as H3O+ to the 2′-F-atom quite likely provides the
driving force for this rapid unimolecular reaction (see Figure 3).
Therefore, we propose that C3′• in one-electron oxidized MeFdC
readily converts to C2′• via a barrierless F− loss (see reaction 5,
Figure 3, and Supporting Information S5).
Theoretical. Comparison of the Theoretically Calculated
HFCC Values of Radicals with Their Experimentally
Obtained HFCC Values. The ωb97x/6-31G(d) calculated
HFCCs of C3′• and C2′• found in gemcitabine and in
MeFdC along with experimental HFCCs (in Gauss) are pre-
sented in Table 1. It is evident from Table 1 that experimental
and theoretically calculated HFCCs are in reasonably good
agreement.
Mechanism of C3′• to C2′• Conversion in MeFdC. To
explore the reaction mechanism of C2′• formation from C3′•
in one-electron oxidized MeFdC and gemcitabine, using the
DFT ωb97x/6-31G(d) method, we considered three possible
reaction paths: (i) HF loss due to deprotonation of 3′-hydroxyl
group,5−7 (ii) HF loss due to ﬂuorine dissociation,5−7 and
additionally, (iii) HF loss in the presence of a hydronium ion
(H3O
+).
The electronic energy proﬁle of HF loss from C3′• in
MeFdC and also from C3′• in gemcitabine in the presence of
a water molecule is shown in Figure S4 in the Supporting
Information. From Supporting Information Figure S4A, it is
evident that for C3′• of MeFdC, the formation of C2′• via HF
loss with deprotonation of 3′-OH has a signiﬁcant barrier of ca.
18 kcal/mol. For C3′• in gemcitabine, the HF loss associated
with deprotonation of 3′-hydroxyl group was calculated to be
ca. 27 kcal/mol (Supporting Information, Figure S4B).
We have also considered the dissociation of ﬂuorine in
C3′• of MeFdC and in C3′• of gemcitabine and found that
stretching the C2′-F bond up to 1.8 Å needs ca. 9 kcal/mol for
C3′• of MeFdC and ca. 17 kcal/mol for C3′• of gemcitabine.
This shows that dissociation of ﬂuorine for C3′• in MeFdC
occurs at lower energy than dissociation of ﬂuorine for C3′• in
gemcitabine (Supporting Information Figure S4).
Alternatively, we consider the fact that deprotonation of H3′
will form H3O
+ initially in close proximity of the C2′-C3′ bond
which may then induce HF loss (reaction 5). Employing the
ωb97x/6-31G(d) method and considering the full solvent
eﬀect through the polarized continuum model (PCM), this
mechanism have been modeled by placing a H3O
+ in the
vicinity of the C3′-OH bond for C3′• in gemcitabine and for
C3′• in MeFdC and have optimized the structures. From our
calculations, we have observed that for C3′• in gemcitabine,
a minimum structure exists in the electronic energy proﬁle in
Figure 3. PCM-ωb97x/6-31G(d) calculated structures of C3′• in (A) gemcitabine and in (B) MeFdC. As indicated in (A) the C3′• in gemcitabine
involves a barrier of 5 kcal/mol (detailed electronic energy proﬁles are provided in Supporting Information Figure S4C,D) to HF loss in the presence
of H3O
+. In (B), the C3′• in MeFdC is unstable in the presence of H3O+ and reacts without a barrier to form C2′• via HF loss. The animations
(movies) of the optimization steps for reaction involving H3O
+ for C3′• in both gemcitabine (A) and MeFdC (B) are provided in the Supporting
Information (S5).
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which the H3O
+ stabilizes the F″-atom through forming a
hydrogen bond (1.57 Å) (see Figure 3A and Supporting
Information Figure S4C). A second minimum structure was
also found in the electronic energy proﬁle in which the H3O
+
stabilizes the F′-atom through forming a hydrogen bond of
identical length, 1.57 Å (see Supporting Information Figure S4D).
A barrier of 5 kcal/mol and the overall reaction energy of −7 to
−8 kcal/mol were found for HF formation in both cases (see
Figure 3A and Supporting Information Figures S4C,D). However,
for C3′• in MeFdC, the H3O+ reacts with the 2′-F-atom without
a barrier and forms HF and C2′• (see Figure 3B). The bond
distances of C3′-O3′ and O3′-H bonds for C3′• in gemcitabine
are calculated as 1.34 Å (primarily C−O single bond character)56
and 0.97 Å, respectively. The values of the corresponding bond
distances of C3′-O3′ and O3′-H bonds for C3′• in MeFdC are
obtained as 1.28 Å (mainly double bond character56 and 1.0 Å
respectively).
Thus, these calculations show that the HF loss from C3′• in
gemcitabine has a ca. 5 kcal/mol barrier (Supporting Information
Figure S4C,D) while for C3′• in MeFdC, the loss of HF is
barrierless, and the C2′• production is exothermic in nature as
shown in Figure 3. These ﬁndings support our experimental
observations that in MeFdC, C3′• is too unstable to be
observed, and only C2′• is found. In contrast, in gemcitabine
only C3′• formation is observed without any conversion to
C2′• in the same temperature range.
■ CONCLUSION
Our work has the following two salient ﬁndings: (i) One
electron oxidation leads to cytosine base π-cation radical (C•+)
in 2′-dC and 2′-F-dC but to C3′• in gemcitabine. As expected
from the one-electron redox potentials of the bases and the
backbone,27−30,57−59 one-electron oxidation of 2′-dC and 2′-F-
dC leads to C•+ formation as evidenced by the ca. 16 G doublet
that is characteristic of C•+. However, gemcitabine (Scheme 1)
leads to the formation of C3′• on one-electron oxidation. The
two highly electronegative F-atoms at 2′-position, through their
negative inductive eﬀect, lead to a substantial increase in the
acidity of H3′. Therefore, C•+ in gemcitabine is highly unstable
toward the loss of H3′ as deprotonation at 150−155 K. This
is evidenced by the free energy changes of the cation radical
for the loss of H3′ as deprotonation to the surrounding solvent
(see Supporting Information Table T2); this deprotonation
shifts the unpaired spin from the cytosine base of metastable
C•+ in gemcitabine to sugar at C3′• via a PCET process.
(ii) C2′• formation does not occur in gemcitabine but does
in its analog MeFdC. It has been proposed in the literature that
in gemcitabine both C3′• and C2′• (reactions 1 and 2) play an
important role in the RNR inactivation.5−7 Conversion of C3′•
to C2′• takes place via an irreversible F− loss from C2′ during
RNR inactivation by gemcitabine.5−7 However, experimental
and theoretical results shown in this work have clearly
demonstrated that in our system (supercooled homogeneous
glassy solutions), C3′• in gemcitabine does not convert to
C2′• on annealing up to 170 K owing to theoretically predicted
barrier of greater than 5 kcal/mol. Theoretically, DFT calcula-
tions support the mechanism involving a H3O
+ induced
barrierless conversion of C3′• to C2′• in one-electron oxidized
MeFdC. Experimentally, C2′• is observed in one-electron
oxidized MeFdC upon annealing to ca. 160−170 K. Thus, our
study in one-electron oxidized MeFdC provides the ﬁrst evidence
of formation of C2′• (via the unstable intermediate C3′•
(reaction 5)) in a nonenzymatic system even at low temperature.
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